Provide problem-oriented innovations in Omics to address technological obstacles.
We provide problem-oriented innovations in Omics to address technological obstacles.
Omics technologies, integrated into a systems biology approach, are now at the core of research in microbiology and infectious diseases. However, to be fully part of the industrial value-chain, Omics solutions need to be tailored to the specific processes and needs of industries.
To accomplish this, BIOASTER has designed and implemented the concept of SMART Omics for the application of Omics technologies to your R&D for the development of new drugs or vaccines, the identification of reliable biomarkers, and the understanding of host/microbiota/pathogen interactions.
We provide problem-oriented Omics approaches that are tailored to specific industrial needs.
Omics is a powerful approach at the discovery phase of research that facilitates a deep understanding of biological systems. To leverage Omics in applied research, we use problem-oriented approaches that are focused on the specific needs of our industrial partners. We harness state-of-the-art fundamental research and adapt or design new Omics technologies for use in our collaborative projects.
From sample preparation to data interpretation
From description to function
From the microbe to the host response
Omics are not limited to the use of cutting-edge instruments to generate data. They involve a complete value-chain that leverages knowledge and expertise in automated sample preparation, molecular analysis, and data analysis through bioinformatics and biostatistics. Access to both the necessary equipment and expertise on a single site facilitates successful Omics studies at BIOASTER.
An Omics hub must be connected with other technologies and be applicable to all the research fields in microbiology.
Finally, Omics approaches are only powerful if they are integrated with other upstream and downstream technologies, such as clinical or preclinical sample collection and advanced data management and analysis. That is why Omics approaches at BIOASTER are part of a global scientific and technological strategy and are developed with the participation of leaders in other technologies and experts in their fields of research.
Genomics & Transcriptomics, Proteomics, Metabolomics & Lipidomics
To answer systems biology questions using Omics technologies, we need to address the entire molecular composition of a biological system. Genomics, Transcriptomics, Metabolomics, and Proteomics are the four pillars of biomolecular research, and BIOASTER integrates these approaches, together with advanced bioinformatics tools, to provide a comprehensive molecular Omics strategy.
Execution of Omics projects according to industrial standards.
Another key to successful collaborative projects in applied research is the reliability, robustness, and reproducibility of Omics techniques. Our Omics projects are designed with the industrial deliverables and processes in mind, and particularly with reference to their quality and deployment. Moreover, as time is often the essence, our Omics studies are aligned with industrial time-frames.
The Omics hub aims to characterize all the molecular entities present in a biological sample using four approaches: genomics, transcriptomics, proteomics, and metabolomics. Two principal technical strategies are used:
- The discovery approach, which is hypothesis-generating and based on our most advanced technologies, including 2nd and 3rd-generation sequencing, high-resolution mass spectrometry, and nuclear magnetic resonance spectroscopy.
We leverage bioinformatics, biostatistics, and AI to deliver high-quality data to permit better understanding of biological mechanisms or the discovery of useful biomarkers.
- The monitoring approach, which is hypothesis-driven and based on highly sensitive and robust technologies, such as multiplex qPCR, 16S sequencing, quantitative mass spectrometry, and nuclear magnetic resonance spectroscopy.
We focus on reliability, robustness, and tailored programs, to generate quantitative data for target validation or the assessment of potential biomarkers.
SMART Omics represents both a strategy and a commitment to provide problem-oriented and integrated Omics technologies, and is performed to industrial standards. Thus, for your Omics needs, you will have access not only to cutting edge equipment, but also to substantial expertise in automated sample preparation, molecular analysis, and data analysis through bioinformatics and biostatistics.
The Omics hub at BIOASTER is integrated with other upstream and downstream technologies, such as clinical or preclinical sample collection and advanced data management and analysis.
Thus, Omics represent part of a global scientific and technological strategy, and you benefit from the knowledge and expertise of a highly-integrated team of leaders in technology and experts in their research fields.
This site is registered on wpml.org
as a development site.